Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

Advanced Search

Basic Search

Help

AND OR NOT

Add a row

Reset

Limit results by

Books+ Search Results

Author

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.

Title

Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

Publication

Washington : U.S. Government Publishing Office, 2015.

Distribution

Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office

Physical Description

iv, 217 pages ; 24 cm

Notes

Shipping list no.: 2015-0330-P.

"Serial No. 113-147."

Other formats

Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEand FDA regulation

Format

Books

Language

English

Added to Catalog

September 02, 2015

Bibliography

Includes bibliographical references.

Subjects

Drugs of abuse > Law and legislation > United States.

Drugs > Law and legislation > United States.

Drug approval > United States.